ISHITADRPharmaceuticals
Ishita Drugs & Industries Ltd — Cash Flow Statement
₹69.11
-11.27%
Ishita Drugs & Industries Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -3.82 Cr | 2.09 Cr | -3.03 Cr | 3.06 Cr | — |
| Issuance Of Debt | 4.12 Cr | — | — | — | — |
| Capital Expenditure | -0.18 Cr | -0.03 Cr | -0.13 Cr | -0.02 Cr | — |
| End Cash Position | 4.83 Cr | 4.81 Cr | 3.43 Cr | 4.68 Cr | — |
| Beginning Cash Position | 4.81 Cr | 3.43 Cr | 4.68 Cr | 2.54 Cr | — |
| Changes In Cash | 0.02 Cr | 1.38 Cr | -1.25 Cr | 2.14 Cr | — |
| Financing Cash Flow | 4.33 Cr | -0.87 Cr | 1.05 Cr | 16884.00 | — |
| Net Other Financing Charges | 0.28 Cr | 0.18 Cr | 0.14 Cr | 0.07 Cr | — |
| Interest Paid Cff | -0.07 Cr | -0.09 Cr | -0.05 Cr | -0.02 Cr | — |
| Net Issuance Payments Of Debt | 4.12 Cr | -0.96 Cr | 0.96 Cr | -0.04 Cr | — |
| Net Long Term Debt Issuance | 4.12 Cr | -0.96 Cr | 0.96 Cr | -0.04 Cr | — |
| Long Term Debt Issuance | 4.12 Cr | — | — | — | — |
| Investing Cash Flow | -0.67 Cr | 0.13 Cr | 0.59 Cr | -0.93 Cr | — |
| Dividends Received Cfi | 4000.00 | 9000.00 | 12891.00 | 3802.00 | — |
| Net Investment Purchase And Sale | -0.48 Cr | 0.16 Cr | 0.73 Cr | -0.95 Cr | — |
| Sale Of Investment | 0.05 Cr | 0.16 Cr | 0.73 Cr | 0.04 Cr | — |
| Purchase Of Investment | -0.53 Cr | — | — | -0.95 Cr | — |
| Net PPE Purchase And Sale | -0.18 Cr | -0.03 Cr | -0.13 Cr | -0.02 Cr | — |
| Sale Of PPE | 0.00 | 0.00 | — | — | — |
| Purchase Of PPE | -0.18 Cr | -0.03 Cr | -0.13 Cr | -0.02 Cr | — |
| Capital Expenditure Reported | 0.00 | 0.00 | — | — | — |
| Operating Cash Flow | -3.64 Cr | 2.12 Cr | -2.90 Cr | 3.08 Cr | — |
| Change In Working Capital | -4.64 Cr | 1.21 Cr | -3.66 Cr | 1.99 Cr | — |
| Change In Payable | 0.51 Cr | -0.33 Cr | -1.43 Cr | 1.38 Cr | — |
| Change In Inventory | -3.40 Cr | 0.53 Cr | -0.62 Cr | -0.32 Cr | — |
| Change In Receivables | -1.45 Cr | 1.30 Cr | -1.45 Cr | 1.09 Cr | — |
| Other Non Cash Items | -0.21 Cr | -0.09 Cr | -0.09 Cr | -0.04 Cr | — |
| Deferred Tax | 0.00 | 0.00 | — | — | — |
| Depreciation And Amortization | 0.11 Cr | 0.11 Cr | 0.13 Cr | 0.13 Cr | — |
| Depreciation | 0.11 Cr | 0.11 Cr | 0.13 Cr | 0.13 Cr | — |
| Gain Loss On Investment Securities | -0.05 Cr | -0.10 Cr | -0.06 Cr | -0.04 Cr | — |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | — | — | — |
| Net Income From Continuing Operations | 1.16 Cr | 0.99 Cr | 0.78 Cr | 1.04 Cr | — |
| Repayment Of Debt | — | -0.96 Cr | — | — | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | — | — | -1.00 |
| Net Short Term Debt Issuance | — | -0.96 Cr | 0.96 Cr | -0.04 Cr | -0.25 Cr |
| Long Term Debt Payments | — | -0.96 Cr | — | — | — |
| Net Other Investing Changes | — | 1000.00 | 0.06 Cr | 0.04 Cr | 0.27 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ishita Drugs & Industries Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.